Sanofi (NASDAQ:SNY) has executed the primary tranche of its €5 billion inventory buyback program.
A primary tranche of this program was introduced on February 3, 2025, and executed on February 5, 2025, for an quantity of €3 billion, via an off-market block commerce with the long-standing